亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

深圳石金谷科技有限公司  

化學合成原料藥、醫藥中間體、化工原料、香精香料、食品輔料、植物提取物

搜索
新聞中心
  • 暫無新聞
產品分類
聯系方式
  • 聯系人:劉艷平
  • 電話:0755-61930350
  • 郵件:sz09@yccreate.com
  • 傳真:0755-84556470
  • QQ:2355880511
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 廠家供應CAS:5534-09-8丙酸倍氯米松原料
廠家供應CAS:5534-09-8丙酸倍氯米松原料
單價 面議對比
詢價 暫無
發貨 廣東深圳市付款后3天內
品牌 南箭
型號 5534-09-8
規格 醫藥級
過期 長期有效
更新 2013-08-13 11:02
 
詳細信息
廠家供應CAS:5534-09-8丙酸倍氯米松原料
丙酸倍氯米松 
產品名稱:丙酸倍氯米松 
英文名稱:Beclometasone dipropionate 
別 名:氯地米松 二丙酸倍氯米松 
CAS 編號:5534-09-8 
版 本: USP31 
分 子 式:C28H37ClO7 
分 子 量:521.05 
包 裝:鋁聽包裝
性 狀:類白色或微黃色結晶性粉末
主要用途:腎上腺皮質激素類藥,可用于治療各種炎癥皮膚病

Beclometasone Dipropionate USP31
product Name: Beclometasone Dipropionate 
CAS Registry Number: 5534-09-8
Packaging: 1kg/Aluminum foil bag
Quality Standards: USP31
Molecular Formula: C28H37ClO7 
Molecular Weight: 521.05 
EINECS: 226-886-0
Appearance: White or yellowish crystalline powder
Usage: Pharmaceutical Intermediates
©2025 深圳石金谷科技有限公司 版權所有   技術支持:化工網   訪問量:28902  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |